ARCHIVES
VOL. 9, ISSUE 5 (2023)
Strategy for managing antithrombotic therapy in periprocedural period in gastrointestinal endoscopy
Authors
G Valcheva, D Notev, I Kostov
Abstract
The main function of antithrombotic therapy is to reduce the risk of
thromboembolic episodes in patients with high risk. Although their important
role in cardiovascular prevention, these agents are the most often reason
for bleeding when undertaking endoscopic procedures. On the other, hand there
is also a risk of thromboembolic sequelae if they are withheld. The bleeding
risk depends on the type of endoscopic procedure, define as low or high-risk
ones. The recommendation in high-risk endoscopic procedures is to stop the
antithrombotic agents and to initiate therapy with LWMH for patients on
vitamin K antagonist known as “bridging”. There is no need
antithrombotic therapy in endoscopic procedures with lower bleeding risk to
be withheld. The strategy for
managing this therapy when these patients need gastrointestinal (GI) endoscopic
procedures should be based on balancing the bleeding risk against the
thromboembolic risk in collaboration with cardiologist.
Download
Pages:21-27
How to cite this article:
G Valcheva, D Notev, I Kostov "Strategy for managing antithrombotic therapy in periprocedural period in gastrointestinal endoscopy". International Journal of Medical and Health Research, Vol 9, Issue 5, 2023, Pages 21-27
Download Author Certificate
Please enter the email address corresponding to this article submission to download your certificate.